658693

Pd(II) EnCat^® BINAP30

extent of labeling: 0.39 mmol/g Pd loading, BINAP 0.25, Pd 1.0

• Synonym(e): Palladiumacetat und BINAP, in Polyharnstoffmatrix microeingekapselt
• MDL-Nummer: MFCD07785498
• UNSPSC-Code: 12161600
• NACRES: NA.22

Eigenschaften

• Zusammensetzung: BINAP, 0.25 ; Pd, 1.0
• Qualitätsniveau: 200
• Eignung der Reaktion: core: palladium; reaction type: Buchwald-Hartwig Cross Coupling Reaction; reaction type: Heck Reaction; reaction type: Hiyama Coupling; reaction type: Negishi Coupling; reaction type: Sonogashira Coupling; reaction type: Stille Coupling; reaction type: Suzuki-Miyaura Coupling; reagent type: catalyst
• Kennzeichnungsgrad: 0.39 mmol/g Pd loading

Beschreibung

Allgemeine Beschreibung

It is Pd EnCat^® catalyst, wherein palladium acetate and 1,1′-binaphthalene-2,2′-diylbis(diphenylphosphine) (BINAP) are microencapsulated within a polyurea matrix, which prevents palladium leaching.

Anwendung

Reaxa Technology

Leistungsmerkmale und Vorteile

The advantage of Pd EnCat^® catalysts are:

• Low residual metal levels in crude product.
• Easy recovery of catalyst.
• Compatibility of immobilized metal with various ligands to effect C–C bond forming reactions.
• Safer and easier to handle than Pd/C for hydrogenation.
• Efficiency and economy gains through recovery and recycling.

Rechtliche Hinweise

Pd Encat technology, international patents have been applied for, including PCT/GB 02/03135.

EnCat is a registered trademark of Reaxa Ltd.

Sicherheitshinweise

• Piktogramme: GHS02,GHS08,GHS07
• Signalwort: Danger
• H-Sätze: H228,H315,H319,H360Df,H373,H412
• P-Sätze: P202 - P210 - P273 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Gefahreneinstufungen: Aquatic Chronic 3 - Eye Irrit. 2 - Flam. Sol. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 Inhalation
• Zielorgane: Nervous system
• WGK: WGK 3
• Persönliche Schutzausrüstung: dust mask type N95 (US), Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges